Page last updated: 2024-10-22

amobarbital and Carcinoma, Squamous Cell

amobarbital has been researched along with Carcinoma, Squamous Cell in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
COSTACHEL, O1
NASTAC, E1
ILIE, B1

Other Studies

1 other study available for amobarbital and Carcinoma, Squamous Cell

ArticleYear
[Influence of vaccinia virus associated with narcosis on the evolution of the Guerin T8 epithelioma in rats].
    Studii si cercetari de inframicrobiologie, 1959, Volume: 10

    Topics: Amobarbital; Animals; Biological Evolution; Carcinoma; Carcinoma, Squamous Cell; Neoplasms, Experime

1959